Replies to post #17357 on Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Thank you,



Well

That might have to change. No reason to hold up one for the other unrelated issue. I hope Momenta argues that as something that should change while they are discussing all the biosimilar issues.

Boing X 2